Klaus Fechner

1.4k total citations
36 papers, 1.2k citations indexed

About

Klaus Fechner is a scholar working on Behavioral Neuroscience, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Klaus Fechner has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Behavioral Neuroscience, 11 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Klaus Fechner's work include Stress Responses and Cortisol (13 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (4 papers). Klaus Fechner is often cited by papers focused on Stress Responses and Cortisol (13 papers), Receptor Mechanisms and Signaling (5 papers) and Neuropeptides and Animal Physiology (4 papers). Klaus Fechner collaborates with scholars based in Germany, United States and Poland. Klaus Fechner's co-authors include Jens Furkert, Michael Bienert, Michael Beyermann, Birgit Roloff, Andrzej Słomiński, Ralf Paus, Eberhard Krause, J. Zipper, Vladimir A. Botchkarev and B. Mehlis and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Biochemistry.

In The Last Decade

Klaus Fechner

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Klaus Fechner Germany 20 290 261 214 177 145 36 1.2k
Marc Mathieu France 23 93 0.3× 738 2.8× 33 0.2× 72 0.4× 87 0.6× 46 1.6k
Yasuhiro Matsumoto Japan 18 14 0.0× 273 1.0× 58 0.3× 185 1.0× 49 0.3× 67 1.2k
Yukio Ito Japan 22 52 0.2× 442 1.7× 12 0.1× 109 0.6× 526 3.6× 58 2.1k
Tadahide Furuno Japan 24 23 0.1× 1.0k 4.0× 104 0.5× 85 0.5× 45 0.3× 95 1.9k
Chandrani Sarkar United States 19 79 0.3× 585 2.2× 26 0.1× 41 0.2× 65 0.4× 30 1.6k
Debanjan Chakroborty United States 18 79 0.3× 581 2.2× 26 0.1× 40 0.2× 65 0.4× 26 1.5k
Michael Young United States 23 59 0.2× 633 2.4× 12 0.1× 55 0.3× 55 0.4× 47 1.8k
W. Born Switzerland 22 44 0.2× 701 2.7× 37 0.2× 22 0.1× 334 2.3× 53 1.4k
H. Christian Weber United States 26 26 0.1× 1.0k 4.0× 42 0.2× 138 0.8× 109 0.8× 83 2.7k
Isao Morimoto Japan 23 20 0.1× 499 1.9× 13 0.1× 49 0.3× 410 2.8× 85 1.7k

Countries citing papers authored by Klaus Fechner

Since Specialization
Citations

This map shows the geographic impact of Klaus Fechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Klaus Fechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Klaus Fechner more than expected).

Fields of papers citing papers by Klaus Fechner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Klaus Fechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Klaus Fechner. The network helps show where Klaus Fechner may publish in the future.

Co-authorship network of co-authors of Klaus Fechner

This figure shows the co-authorship network connecting the top 25 collaborators of Klaus Fechner. A scholar is included among the top collaborators of Klaus Fechner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Klaus Fechner. Klaus Fechner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beyermann, Michael, Klaus Fechner, Jens Furkert, et al.. (2009). Ago-Antagonists for G Protein-Coupled Peptide Hormone Receptor by Modifying the Agonist's Signalling Domain. Advances in experimental medicine and biology. 611. 541–542.
2.
Klose, Jana, et al.. (2008). Synthesis of Protein Mimics with Nonlinear Backbone Topology by a Combined Recombinant, Enzymatic, and Chemical Synthesis Strategy. Angewandte Chemie International Edition. 47(19). 3642–3645. 32 indexed citations
3.
Beyermann, Michael, et al.. (2007). Achieving signalling selectivity of ligands for the corticotropin‐releasing factor type 1 receptor by modifying the agonist's signalling domain. British Journal of Pharmacology. 151(6). 851–859. 29 indexed citations
4.
Klose, Jana, Eberhard Krause, Klaus Fechner, et al.. (2004). Hexa‐histidin tag position influences disulfide structure but not binding behavior of in vitro folded N‐terminal domain of rat corticotropin‐releasing factor receptor type 2a. Protein Science. 13(9). 2470–2475. 38 indexed citations
5.
Furkert, Jens, et al.. (2004). Regulation of the Coupling to Different G Proteins of Rat Corticotropin-releasing Factor Receptor Type 1 in Human Embryonic Kidney 293 Cells. Journal of Biological Chemistry. 279(37). 38386–38394. 40 indexed citations
6.
Słomiński, Andrzej, Birgit Roloff, Blazej Zbytek, et al.. (2000). CORTICOTROPIN RELEASING HORMONE AND RELATED PEPTIDES CAN ACT AS BIOREGULATORY FACTORS IN HUMAN KERATINOCYTES. In Vitro Cellular & Developmental Biology - Animal. 36(3). 211–211. 51 indexed citations
7.
Beyermann, Michael, Sven Rothemund, Klaus Fechner, et al.. (2000). A Role for a Helical Connector between Two Receptor Binding Sites of a Long-chain Peptide Hormone. Journal of Biological Chemistry. 275(8). 5702–5709. 45 indexed citations
8.
Roloff, Birgit, Klaus Fechner, Andrzej Słomiński, et al.. (1998). Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. The FASEB Journal. 12(3). 287–297. 77 indexed citations
9.
Gold, Garry E., Daniel R. Thedens, John M. Pauly, et al.. (1998). MR imaging of articular cartilage of the knee: new methods using ultrashort TEs.. American Journal of Roentgenology. 170(5). 1223–1226. 89 indexed citations
10.
Rohde, E, Jens Furkert, Klaus Fechner, et al.. (1996). Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochemical Pharmacology. 52(6). 829–833. 35 indexed citations
11.
Roloff, Birgit, Michael Beyermann, Margitta Dathe, et al.. (1995). The effect of dibenzofuran substitutions in corticotropin-releasing factor. Letters in Peptide Science. 2(3-4). 209–211. 1 indexed citations
12.
Bude, Ronald O., Jonathan M. Rubin, J F Platt, Klaus Fechner, & Ronald S. Adler. (1994). Pulsus tardus: its cause and potential limitations in detection of arterial stenosis.. Radiology. 190(3). 779–784. 69 indexed citations
13.
Ellis, James H., Isaac R. Francis, Michael Rhodes, N M Kane, & Klaus Fechner. (1991). CT Findings in Tuboovarian Abscess. Journal of Computer Assisted Tomography. 15(4). 589–592. 16 indexed citations
14.
Rafler, G., et al.. (1990). Synthesis and properties of biodegradable aliphatic polyesters. British Polymer Journal. 23(3). 235–240. 43 indexed citations
15.
Chenevert, Thomas L., Klaus Fechner, & Daphna Y. Gelblum. (1989). Improvements in MR Angiography Using Phase‐Corrected Data Sets. Magnetic Resonance in Medicine. 10(1). 38–49. 7 indexed citations
16.
18.
Quint, Leslie E., G M Glazer, Thomas L. Chenevert, et al.. (1988). In vivo and in vitro MR imaging of renal tumors: histopathologic correlation and pulse sequence optimization.. Radiology. 169(2). 359–362. 24 indexed citations
19.
Meyer, Charles R., et al.. (1988). Feasibility of high-resolution, intravascular ultrasonic imaging catheters.. Radiology. 168(1). 113–116. 79 indexed citations
20.
Dautzenberg, H., F. Loth, Klaus Fechner, B. Mehlis, & K. Pommerening. (1985). Preparation and performance of symplex capsules. Die Makromolekulare Chemie. 9(S19851). 203–210. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026